Uncategorized

BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work

Published

5 hours ago

on

BridgeBio Oncology Therapeutics is replacing CEO Eli Wallace, putting its CSO Pedro Beltran in the role, and making board member Neil Kumar executive chairman.

The changes come as there’s been growing competition in cancer over …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version